About carl zeiss meditec ag - CZMWY
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Strategic Business Unit (SBU) and Microsurgery business SBU segments. The Ophthalmic SBU segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery SBU segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded in 2002 and is headquartered in Jena, Germany.
CZMWY At a Glance
Carl Zeiss Meditec AG
Göschwitzer Strasse 51-52
Jena, Thueringen 07745
| Phone | 49-3641-220331 | Revenue | 2.24B | |
| Industry | Medical Specialties | Net Income | 193.73M | |
| Sector | Health Technology | 2024 Sales Growth | 0.499% | |
| Fiscal Year-end | 09 / 2025 | Employees | 5,730 | |
| View SEC Filings |
CZMWY Valuation
| P/E Current | 30.356 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 36.419 |
| Price to Sales Ratio | 3.15 |
| Price to Book Ratio | 3.051 |
| Price to Cash Flow Ratio | 26.318 |
| Enterprise Value to EBITDA | 19.673 |
| Enterprise Value to Sales | 3.461 |
| Total Debt to Enterprise Value | 0.091 |
CZMWY Efficiency
| Revenue/Employee | 390,855.918 |
| Income Per Employee | 33,810.175 |
| Receivables Turnover | 3.442 |
| Total Asset Turnover | 0.636 |
CZMWY Liquidity
| Current Ratio | 2.132 |
| Quick Ratio | 1.188 |
| Cash Ratio | 0.036 |
CZMWY Profitability
| Gross Margin | 52.689 |
| Operating Margin | 11.167 |
| Pretax Margin | 11.804 |
| Net Margin | 8.65 |
| Return on Assets | 5.501 |
| Return on Equity | 8.488 |
| Return on Total Capital | 6.499 |
| Return on Invested Capital | 7.094 |
CZMWY Capital Structure
| Total Debt to Total Equity | 30.825 |
| Total Debt to Total Capital | 23.562 |
| Total Debt to Total Assets | 18.328 |
| Long-Term Debt to Equity | 28.685 |
| Long-Term Debt to Total Capital | 21.926 |
Carl Zeiss Meditec Ag in the News
EU may struggle to catch up with U.S., Asia in chips subsidies race
The EU Chips Act aims to tempt top chipmakers to manufacture in the region, but modest budget could impede attempts to catch up with the markets US and Asia.